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Key summary points
Aim To report on the 2019 EuGMS Congress in Krakow.
Findings Evidence-based medicine in geriatrics is a previously neglected, now rapidly expanding field. Heterogeneity of 
our older population brings many questions and challenges for research.
Message Personalized approaches based on evidence-based practices, standardisation of definitions and meaningful out-
comes, in collaboration with older people themselves, and with other specialties, are the new frontiers and challenges for 
research.
Abstract
The 2019 EuGMS Congress “Evidence-Based Medicine in Geriatrics” was held in Krakow, Poland, and attended by over 
1600 participants from 64 different countries. A summary and reflection on the congress was presented in the Closing Cer-
emony by European Academy for Medicine of Aging graduates, and summarised in this article. Keynote lectures, ‘state of the 
art’ sessions and symposia presented the evidence relating to different age-related conditions, their prevention, management 
and treatments. Hot topic areas included frailty and multimorbidity, and evidence-based attempts to address these conditions 
at different life stages. The field of geriatrics represents unique challenges for evidence-based medicine practice. There is 
much research going on. Clear leadership is needed to facilitate consensus agreements on standard definitions, methods and 
relevant outcomes, in collaboration with older people themselves, to maximise the opportunities and benefits of doing this 
research, and benefiting our patients and society at large.
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Introduction
Evidence-based medicine (EBM) was first described by 
David L. Sackett as the “conscientious, explicit and judi-
cious use of the best current clinical research evidence 
in making decisions about the care of patients”[1]. This, 
however, may not be straightforward in geriatric medicine: 
heterogeneity can be difficult to take account of in classic 
randomized controlled trials (RCTs), with the widespread 
use of age or comorbidity cut-offs [2], in addition to practi-
cal recruitment issues. It can thus be challenging to answer 
with EBM the sorts of questions we and our older patients 
may have. To address this issue, the 15th EuGMS congress 
was dedicated to EBM. This brief report picks out some of 
the many topics covered.
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Evidence‑based medicine in geriatrics
The traditional pyramid of evidence-based medicine is 
evolving [3], Fig. 1. Traditionally, older patients have been 
systematically excluded from high-quality RCTs [2, 4] or 
those included are mainly the ‘robust’ ones, still fitting 
more ‘single disease’ criteria. Straightforward extrapola-
tion of apparently robust evidence from studies in younger 
people and often single condition studies, is not often 
appropriate in more frail older patients with potentially 
several comorbidities. The complex interplay of physi-
ological, psychological and social differences makes each 
older patient—and their potential response to a given treat-
ment or situation—unique. Designing “traditional” ran-
domised control trials are rarely possible in this group, 
because of the complexities involved in the research ques-
tions, the patients, and the healthcare systems. In studying 
multimorbidity, for example, trying to define which and 
how many diseases count, or even finding standard disease 
classifications can lead to real issues in designing practi-
cal, meaningful and reproducible study designs. Attempts 
at systematic reviews and meta-analyses are made, using 
the PICO question (Fig. 2). But the complexities previ-
ously mentioned mean that consensus statements, incorpo-
rating the myriad of different trials (with varying inclusion 
and exclusion criteria, designs and outcomes) with expert 
opinions, are often needed. None of this is easy, however. 
Franz Messerli in his opening lecture, described clearly the 
rift sometimes apparent between those who preach, teach 
and treat: part of this confusing scenario may result from 
the fact that those very few who preach rarely treat, those 
few more who teach only sometimes treat, and those many 
who treat do not always listen, neither to those who preach 
nor to those who teach! 
EBM in the prevention and healthy ageing
A resounding message from the congress was that exercise 
at every stage of life is vital and we should promote it much 
more. It should be viewed as a medicine—consider recom-
mending a dose, a time and a frequency. Regular physical 
activity can reduce the risk of hip fracture by up to 68%, type 
Fig. 1  Evidence-based medicine 
[3]
P - Problem or Paent or Populaon 
I - Intervenon/indicator 
C – Comparison 
O - Outcome of interest 
Fig. 2  PICO model for clinical or research questions
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2 diabetes up to 40%, cardiovascular disease by up to 35%, 
dementia, depression, colon cancer and all-cause mortal-
ity each by up to 30% [5]. Multiple presentations showed 
the interest and ongoing research in the field of prehabilita-
tion, particularly ahead of oncology treatment and surgi-
cal treatments. Increasing evidence suggests prehabilitation 
can result in significantly improved return to health, but that 
larger-scale RCTs (especially in oncology) are still needed.
A submitted symposium highlighted the increasing evi-
dence of an interplay between gut microbiota and physical 
function [6], cognitive health and infections—but there is 
still much we do not understand about the gut and gut physi-
ology in ageing.
Stefania Maggi told us in a Keynote session that vac-
cination annually saves > 2.5 million deaths related to com-
municable diseases. At the same time reduction in all car-
diovascular events was associated with vaccination [7]. This 
should be considered as a new outcome in clinical trials for 
vaccines.
EBM in age‑related conditions
The results from the European MID-Frail study were pre-
sented, a 12-month multimodal intervention in older people 
with type 2 diabetes. This demonstrated improvements in 
frailty and quality of life, and in a cost-effective manner 
[8]. This is important as diabetes is a risk factor for prema-
ture disability and dementia, frailty is a major risk factor in 
increased risk of death or disability, and the rates of all are 
increasing.
Managing blood pressure in older people is still a chal-
lenge and with ongoing debate and current research looking 
at optimal target blood pressure measurements for our older 
and more frail population. Recalling the past can sometimes 
be illuminating, however: attendees were astonished at the 
high systolic blood pressures people lived with only a few 
decades ago [9].
The updated European guidance for the Diagnosis and 
Management of Osteoporosis in Postmenopausal Women 
were presented [10]. Surprising evidence showed the rates 
of osteoporosis prescriptions has fallen over the last two dec-
ades, despite the advent of orthogeriatrics as a subspeciality 
in many countries. We need to continue assessing risk and 
trying to ensure if it occurs, and adhere to the mantra the 
“first break is the last”.
A dedicated session on ageing with HIV highlighted the 
fact that geriatricians most probably will encounter HIV 
survivors due to the advances made in HIV treatment over 
the last decades.
Cancer frequency increase with age. At present most can-
cer treatment approaches remain tumour-centric, although 
frailty has been shown to predict complication rates. At 
present, the majority of oncology multidisciplinary team 
meetings (MDTs) do not consider frailty or “patient-related” 
factors. Early EBM in this field demonstrated incorpora-
tion of comprehensive geriatric assessment (CGA) into 
oncology MDTs led to adjusted management in > 70% of 
cases, reduced complications and reduced 90-day mortality 
(Ommundsen et al., unpublished).
EBM in frailty and multimorbidity
A recent systematic review which looked at the effectiveness 
of interventions to prevent pre-frailty and frailty progres-
sion in older adults also summarised current evidence and 
research gaps [11]. As with CGA, multimodal interventions 
seem to be developing the greatest evidence base in many 
of these areas. This will need the incorporation of economic 
evaluations to future studies, to justify potentially multi-
modal (expensive!) interventions.
Amaia Calderon-Larrañaga and colleagues have shown 
distinctly different patterns of multimorbidity in difference 
people, with significantly different sociodemographic, life-
style, clinical, and functional profiles [12]. This could poten-
tially enable targeted preventive approaches.
A consensus report from the global clinical nutrition 
community presented the new Global Leadership Initiative 
on Malnutrition (GLIM) criteria for the diagnosis of mal-
nutrition, involving a two-step approach: first screening to 
identify “at risk” status by the use of any validated screening 
tool, and second, assessment for diagnosis and grading the 
severity of malnutrition [13].
A recent Cochrane review on interventions to improve the 
appropriate use of polypharmacy for older people was incon-
clusive, largely due to the very limited number of studies 
without significant bias [14]. This reflects again the recur-
ring issue of there being many different tools in use and little 
standardisation.
Conclusions
Geriatrics represents unique challenges for evidence-based 
medicine practice. Finbarr Martin pulled all these observa-
tions and reflections together in the Presidential Keynote 
Lecture: ‘twenty-first-century geriatric medicine for twenty-
first-century populations’.
Multimorbidity, frailty, resilience, disability are all com-
plex concepts which take geriatric medicine beyond simple 
medicine. The person-centred approach in geriatrics is fun-
damental to ensuring we focus on the meaningful outcomes, 
and not be distracted by the ‘easily measurable’ alone. Luck-
ily, there are many exciting and high-quality research and 
clinical improvement projects going on throughout Europe!
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We would suggest that strong EuGMS leadership is 
needed to help facilitate consensus agreements on standard 
definitions, methods and relevant outcomes, in collaboration 
with patients and the public, other specialist societies (per-
haps in particular the gerontological societies), to maximise 
the opportunities and benefits of doing meaningful research 
with the aim of working with and benefiting our patients and 
society at large. New technologies for example may help in 
empowering the older population further.
Since drafting this summary a consensus statement call-
ing for alignment of common data measurements and out-
comes has been published by numerous leading researchers 
in geriatrics, frailty and ageing [15].
In the meantime, the COVID-19 pandemic has affected 
the whole world and especially our patients. Moreover, 
major issues such as climate change are going to drasti-
cally affect the future, and should proactively be taken into 
consideration at all points. New frontiers in geriatrics have 
emerged and the need for strong leadership, collaboration 
and use of new technologies have become indispensable.
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